{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:51:23Z","timestamp":1791355883098,"version":"4.3.1"},"reference-count":109,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bloodreviews.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.blre.2015.10.001","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T14:11:07Z","timestamp":1446646267000},"page":"139-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Vaccinations in patients with hematological malignancies"],"prefix":"10.1016","volume":"30","author":[{"given":"C.","family":"Tsigrelis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2015.10.001_bb0005","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/pbc.22771","article-title":"2009 Pandemic influenza A (H1N1) virus infection in pediatric oncology and hematopoietic stem cell transplantation patients","volume":"56","author":"Cost","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2015.10.001_bb0010","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3324\/haematol.2011.041913","article-title":"Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients","volume":"96","author":"Ljungman","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2015.10.001_bb0015","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.vaccine.2010.12.113","article-title":"The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A\/California\/7\/2009 (H1N1)v-like virus vaccine during the 2009 pandemic","volume":"29","author":"Engelhard","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.blre.2015.10.001_bb0020","doi-asserted-by":"crossref","first-page":"619","DOI":"10.7326\/0003-4819-152-9-201005040-00022","article-title":"Respiratory failure caused by 2009 novel influenza A\/H1N1 in a hematopoietic stem-cell transplant recipient: detection of extrapulmonary H1N1 RNA and use of intravenous peramivir","volume":"152","author":"Campbell","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2015.10.001_bb0025","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1607.091691","article-title":"Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus","volume":"16","author":"Tramontana","year":"2010","journal-title":"Australia Emerg Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0030","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1182\/blood-2010-11-319186","article-title":"Differences in clinical outcomes following 2009 influenza A\/H1N1 and seasonal influenza among hematopoietic cell transplant recipients","volume":"117","author":"Choi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.10.001_bb0035","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/cid\/ciu970","article-title":"Disseminated, persistent, and fatal infection due to the vaccine strain of varicella-zoster virus in an adult following stem cell transplantation","volume":"60","author":"Bhalla","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0045","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/bmt.2009.263","article-title":"Vaccination of hematopoietic cell transplant recipients","volume":"44","author":"Ljungman","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2015.10.001_bb0050","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/1097-0142(19920315)69:6<1481::AID-CNCR2820690628>3.0.CO;2-L","article-title":"Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia","volume":"69","author":"Alanko","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2015.10.001_bb0055","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00043426-199809000-00008","article-title":"Immune recovery in children with malignancy after cessation of chemotherapy","volume":"20","author":"Mustafa","year":"1998","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2015.10.001_bb0060","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1182\/blood.V84.2.657.657","article-title":"Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation","volume":"84","author":"Ljungman","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.10.001_bb0065","first-page":"89","article-title":"Response to immunization against polio after allogeneic marrow transplantation","volume":"7","author":"Ljungman","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2015.10.001_bb0070","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/infdis\/162.2.496","article-title":"Response to tetanus toxoid immunization after allogeneic bone marrow transplantation","volume":"162","author":"Ljungman","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0075","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0080","first-page":"450","article-title":"Response to pneumococcal polysaccharide vaccine in patients with untreated Hodgkin's disease","volume":"2","author":"Addiego","year":"1980","journal-title":"Children's Cancer Study Group Report Lancet"},{"key":"10.1016\/j.blre.2015.10.001_bb0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-0609.1989.tb01250.x","article-title":"Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's disease","volume":"43","author":"Frederiksen","year":"1989","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2015.10.001_bb0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0145-2126(97)00155-0","article-title":"Hepatitis B vaccination in acute lymphoblastic leukemia","volume":"22","author":"Goyal","year":"1998","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2015.10.001_bb0095","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1086\/511636","article-title":"Revaccination of children after completion of standard chemotherapy for acute leukemia","volume":"44","author":"Patel","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0100","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/pbc.22135","article-title":"Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination","volume":"53","author":"Zengin","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2015.10.001_bb0105","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1442-200X.1993.tb03080.x","article-title":"Active immunization of children with leukemias and lymphomas against infection by hepatitis B virus","volume":"35","author":"Rokicka-Milewska","year":"1993","journal-title":"Acta Paediatr Jpn"},{"key":"10.1016\/j.blre.2015.10.001_bb0110","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/pbc.21174","article-title":"Immune response to conjugated meningococcal C vaccine in pediatric oncology patients","volume":"49","author":"Yu","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2015.10.001_bb0115","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1365-2141.2005.05582.x","article-title":"Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study","volume":"130","author":"Ljungman","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.10.001_bb0120","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/bmt.2015.49","article-title":"Pretransplant vaccinations in allogeneic stem cell transplantation donors and recipients: an often-missed opportunity for immunoprotection?","volume":"50","author":"Harris","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2015.10.001_bb0125","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1086\/598324","article-title":"Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation","volume":"48","author":"Cordonnier","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0130","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0264-410X(91)90006-R","article-title":"Administration of live attenuated varicella vaccine to children with cancer before starting chemotherapy","volume":"9","author":"Cristofani","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.blre.2015.10.001_bb0135","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.bbmt.2011.05.006","article-title":"Safety and immunogenicity of the live attenuated varicella vaccine following T replete or T cell-depleted related and unrelated allogeneic hematopoietic cell transplantation (alloHCT)","volume":"17","author":"Chou","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2015.10.001_bb0140","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.bbmt.2008.06.012","article-title":"Response to pneumococcal (PNCRM7) and haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (alloHCT)","volume":"14","author":"Pao","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2015.10.001_bb0145","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF00366446","article-title":"The influence of graft versus host reaction on the response to pneumococcal vaccination in bone marrow transplant patients","volume":"1","author":"Hammarstr\u00f6m","year":"1993","journal-title":"J Supportive Care in Cancer"},{"key":"10.1016\/j.blre.2015.10.001_bb0150","first-page":"1","article-title":"Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients","volume":"11","author":"Engelhard","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2015.10.001_bb0155","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1182\/blood-2006-04-006981","article-title":"Immunogeneicyt of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants","volume":"108","author":"Jaffe","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.10.001_bb0160","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s15010-011-0206-5","article-title":"Vaccination against pandemic H1N1 (2009) in patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis","volume":"40","author":"Roll","year":"2012","journal-title":"Infection"},{"key":"10.1016\/j.blre.2015.10.001_bb0165","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/sj.bmt.1700959","article-title":"Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT","volume":"20","author":"Parkkali","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2015.10.001_bb0170","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.bbmt.2010.10.002","article-title":"Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients","volume":"17","author":"Issa","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2015.10.001_bb0175","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/cid\/civ287","article-title":"Immunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged >\/=2years: an open-label study","volume":"61","author":"Cordonnier","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0180","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.bmt.1705562","article-title":"A randomized study on donor immunization with tetanus-diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation","volume":"39","author":"Parkkali","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2015.10.001_bb0185","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1182\/blood.V84.12.4374.bloodjournal84124374","article-title":"Clonal dysregulation of the antibody response to tetanus-toxoid after bone marrow transplantation","volume":"84","author":"Gerritsen","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.10.001_bb0190","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/sj.bmt.1704336","article-title":"Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation","volume":"33","author":"Storek","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2015.10.001_bb0195","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bmt.1704870","article-title":"Vaccination of stem cell transplant recipients: recommendations of the infectious diseases working party of the EBMT","volume":"35","author":"Ljungman","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2015.10.001_bb0200","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/bmt.2009.254","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective","volume":"44","author":"Tomblyn","year":"2009","journal-title":"Preface Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2015.10.001_bb0205","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jama.1997.03540380062032","article-title":"A national survey of immunization practices following allogeneic bone marrow transplantation","volume":"277","author":"Henning","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.blre.2015.10.001_bb0210","first-page":"455","article-title":"Immunisations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European group for blood and marrow transplantation","volume":"15","author":"Ljungman","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2015.10.001_bb0215","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/pbc.22444","article-title":"Post-hematopoietic stem cell transplant immunization practices in the pediatric blood and marrow transplant consortium","volume":"54","author":"Hudspeth","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2015.10.001_bb0220","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/tid.12312","article-title":"Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practice","volume":"16","author":"Ariza-Heredia","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0225","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/tid.12110","article-title":"Vaccination adherence in hematopoietic stem cell transplant patients: a pilot study on the impact of vaccination cards and reminder telephone calls","volume":"15","author":"Lerchenfeldt","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0230","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1054\/bjoc.1999.1088","article-title":"Immunogenicity of vaccination against influenza, streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma","volume":"82","author":"Robertson","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.blre.2015.10.001_bb0235","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1182\/blood.V54.5.1171.1171","article-title":"Use and efficacy of pneumococcal vaccine in patients with Hodgkin disease","volume":"54","author":"Levine","year":"1979","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.10.001_bb0240","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJM197808312990903","article-title":"Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease","volume":"299","author":"Siber","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2015.10.001_bb0245","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-2796.2004.01312.x","article-title":"A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma","volume":"255","author":"Landgren","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/j.blre.2015.10.001_bb0250","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.vaccine.2005.07.054","article-title":"Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases","volume":"24","author":"Cherif","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.blre.2015.10.001_bb0255","doi-asserted-by":"crossref","first-page":"828","DOI":"10.7326\/0003-4819-123-11-199512010-00003","article-title":"Antibody responses to polysaccharide and polysaccharide-conjugate vaccines after treatment of Hodgkin disease","volume":"123","author":"Molrine","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2015.10.001_bb0260","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.vaccine.2007.10.053","article-title":"Antibody response to 7-valent conjugated pneumococcal vaccine in patients with chronic lymphocytic leukaemia","volume":"26","author":"Sinisalo","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.blre.2015.10.001_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114966","article-title":"Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients\u2014preliminary report","volume":"9","author":"Pasiarski","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.blre.2015.10.001_bb0270","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2141.2011.08867.x","article-title":"Better response with conjugate vaccine than with polysaccaride vaccine 12months after rituximab treatment in lymphoma patients","volume":"156","author":"Svensson","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2015.10.001_bb0275","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/infdis\/173.1.256","article-title":"Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease","volume":"173","author":"Chan","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0280","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0022-3476(98)70235-5","article-title":"Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease","volume":"133","author":"Vernacchio","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.blre.2015.10.001_bb0285","first-page":"521","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6\u201318years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.blre.2015.10.001_bb0290","first-page":"816","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.blre.2015.10.001_bb0295","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/infdis\/154.4.590","article-title":"Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine","volume":"154","author":"Giebink","year":"1986","journal-title":"J Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0300","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF01543105","article-title":"Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation","volume":"15","author":"Avanzini","year":"1995","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.blre.2015.10.001_bb0305","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00007890-199403150-00009","article-title":"Polysaccharide conjugate vaccine responses in bone marrow transplant patients","volume":"57","author":"Guinan","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.blre.2015.10.001_bb0310","first-page":"961","article-title":"A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT","volume":"18","author":"Parkkali","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2015.10.001_bb0315","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/archinte.1983.00350090113018","article-title":"Pneumococcal vaccination of recipients of bone marrow transplants","volume":"143","author":"Winston","year":"1983","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.blre.2015.10.001_bb0320","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1182\/blood-2002-03-0832","article-title":"Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation","volume":"101","author":"Molrine","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.10.001_bb0325","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood-2006-06-032284","article-title":"Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation","volume":"109","author":"Meisel","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.10.001_bb0330","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1086\/523583","article-title":"A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients","volume":"45","author":"Kumar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0335","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1016\/j.vaccine.2010.01.025","article-title":"Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trial","volume":"28","author":"Cordonnier","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.blre.2015.10.001_bb0340","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/bmt.2015.42","article-title":"Long-term persistence of the immune response to antipneumococcal vaccines after allo-SCT: 10-year follow-up of the EBMT-IDWP01 trial","volume":"50","author":"Cordonnier","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2015.10.001_bb0345","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/cncr.21203","article-title":"Epidemiology and outcomes of serious influenza-related infections in the cancer population","volume":"104","author":"Cooksley","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2015.10.001_bb0350","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/BF02098469","article-title":"Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy","volume":"12","author":"Lo","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0355","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0953-6205(01)00149-2","article-title":"Influenza virus vaccination and booster in B-cell chronic lymphocytic leukaemia patients","volume":"12","author":"van der Velden","year":"2001","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.blre.2015.10.001_bb0360","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3324\/haematol.2010.032664","article-title":"Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host","volume":"96","author":"de Lavallade","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2015.10.001_bb0365","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.1182\/blood-2011-08-372649","article-title":"Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6months after treatment","volume":"118","author":"Yri","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.10.001_bb0370","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.4049\/jimmunol.1004095","article-title":"Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens","volume":"186","author":"Bedognetti","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.blre.2015.10.001_bb0375","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1086\/313663","article-title":"Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients","volume":"30","author":"Pauksen","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0380","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/sj.bmt.1705159","article-title":"The benefit of influenza vaccination after bone marrow transplantation","volume":"36","author":"Machado","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2015.10.001_bb0385","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/tid.12054","article-title":"European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011)","volume":"15","author":"Engelhard","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0390","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.bbmt.2011.02.004","article-title":"Enhanced immune response after a second dose of an AS03-adjuvanted H1N1 influenza A vaccine in patients after hematopoietic stem cell transplantation","volume":"17","author":"Gueller","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2015.10.001_bb0395","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/TP.0b013e3181772a75","article-title":"Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantation","volume":"86","author":"Avetisyan","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.blre.2015.10.001_bb0400","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/tid.12382","article-title":"Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients","volume":"17","author":"Ambati","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0405","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jama.1984.03350030023016","article-title":"Live attenuated varicella vaccine. Efficacy for children with leukemia in remission","volume":"252","author":"Gershon","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.blre.2015.10.001_bb0410","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1056\/NEJM198904063201403","article-title":"Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine","volume":"320","author":"Gershon","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2015.10.001_bb0415","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0140-6736(07)60567-4","article-title":"Varicella vaccination in a child with acute lymphoblastic leukaemia","volume":"369","author":"Schrauder","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2015.10.001_bb0420","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4161\/hv.26200","article-title":"Fatal varicella due to the vaccine-strain varicella-zoster virus","volume":"10","author":"Leung","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.blre.2015.10.001_bb0425","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/pbc.22759","article-title":"The controversy of varicella vaccination in children with acute lymphoblastic leukemia","volume":"58","author":"Caniza","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2015.10.001_bb0430","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ajh.22196","article-title":"Experience with use of Zostavax((R)) in patients with hematologic malignancy and hematopoietic cell transplant recipients","volume":"87","author":"Naidus","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2015.10.001_bb0435","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bbmt.2013.11.013","article-title":"Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients","volume":"20","author":"Issa","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2015.10.001_bb0440","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1086\/514077","article-title":"Early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine","volume":"176","author":"Redman","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0445","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa013441","article-title":"Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants","volume":"347","author":"Hata","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2015.10.001_bb0450","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1542\/peds.2013-4260","article-title":"An outbreak of measles in an undervaccinated community","volume":"134","author":"Gahr","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.blre.2015.10.001_bb0455","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.vaccine.2014.01.094","article-title":"Impact of measles national vaccination coverage on burden of measles across 29 Member States of the European Union and European Economic Area, 2006\u20132011","volume":"32","author":"Colzani","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.blre.2015.10.001_bb0460","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/511641","article-title":"Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation","volume":"44","author":"Patel","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0465","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.bmt.1704878","article-title":"Early measles vaccination in bone marrow transplant recipients","volume":"35","author":"Machado","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2015.10.001_bb0470","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/infdis\/159.4.610","article-title":"Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine","volume":"159","author":"Ljungman","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0475","first-page":"300","article-title":"Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices","volume":"64","author":"Petrosky","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.blre.2015.10.001_bb0480","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1053\/j.seminhematol.2011.10.002","article-title":"Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management","volume":"49","author":"Shanis","year":"2012","journal-title":"Semin Hematol"},{"key":"10.1016\/j.blre.2015.10.001_bb0485","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.bbmt.2011.09.012","article-title":"A clinical study of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation","volume":"18","author":"Wang","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2015.10.001_bb0490","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.tmaid.2014.04.009","article-title":"The medically immunocompromised adult traveler and pre-travel counseling: status quo 2014","volume":"12","author":"Askling","year":"2014","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0495","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tmaid.2014.12.007","article-title":"Travel risk assessment, advice and vaccinations in immunocompromised travellers (HIV, solid organ transplant and haematopoeitic stem cell transplant recipients): a review","volume":"13","author":"Aung","year":"2015","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0500","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jtm.12166","article-title":"International travel patterns and travel risks for stem cell transplant recipients","volume":"22","author":"Mikati","year":"2015","journal-title":"J Travel Med"},{"key":"10.1016\/j.blre.2015.10.001_bb0505","first-page":"1","article-title":"Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Advisory Committee on Immunization Practices (ACIP)","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.blre.2015.10.001_bb0510","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/bmt.2009.110","article-title":"Significant loss of hepatitis A Ab after allogeneic hematopoietic SCT in pediatric patients","volume":"45","author":"Unal Ince","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2015.10.001_bb0515","first-page":"305","article-title":"Updated recommendations for the use of typhoid vaccine\u2014Advisory Committee on Immunization Practices, United States, 2015","volume":"64","author":"Jackson","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.blre.2015.10.001_bb0520","first-page":"1","article-title":"Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Staples","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.blre.2015.10.001_bb0525","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1600-0609.2004.00218.x","article-title":"Yellow fever vaccine: a successful vaccination of an immunocompromised patient","volume":"72","author":"Gowda","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2015.10.001_bb0530","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1708-8305.2009.00336.x","article-title":"Successful immunization of an allogeneic bone marrow transplant recipient with live, attenuated yellow fever vaccine","volume":"16","author":"Yax","year":"2009","journal-title":"J Travel Med"},{"key":"10.1016\/j.blre.2015.10.001_bb0535","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S1473-3099(11)70344-9","article-title":"A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"12","author":"Kharfan-Dabaja","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0540","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/infdis\/jit344","article-title":"Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults","volume":"208","author":"Mullane","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.blre.2015.10.001_bb0545","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X15000788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X15000788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T22:38:25Z","timestamp":1599777505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X15000788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":109,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0268960X15000788"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2015.10.001","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccinations in patients with hematological malignancies","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2015.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}